Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women

Inclusion criteria

• Healthy research participants, with an active sexual life;
• Intact skin and mucosa in the test region;
• Participants vaccinated for COVID-19 (Corona virus Disease).
• Agreement to adhere to the study procedures and requirements and attend the institute on the day(s) and time(s) determined for the assessments;
• Ability to consent to participate in the study;
• Menopausal participants of any age, without systemic or topical hormone replacement therapy in the last 6 months
• Presenting mild to moderate vaginal dryness (≥0.5 and <7.5) - according to the Visual Analogic Scale
• Healthy research participants, with an active sex life (at least once a week)

Exclusion criteria

• Skin pathology in the area of product application;
• Decompensated Diabetes Mellitus (TBD by the institute together with the sponsor);
• Immune insufficiency;
• Current use of the following topical or systemic medications: corticosteroids, immunosuppressants and antihistamines;
• Skin diseases: vitiligo, psoriasis, atopic dermatitis;
• Previous reaction to the category of the product tested;
• Other illnesses or medications that may directly interfere with the study or put the health of the research participant at risk.
• Have used vaginal moisturizing creams and/or intimate lubricants 5 days before the initial study visit;
• Have had sexual intercourse at least 48 hours before the initial study visit;
• Have been diagnosed with a urogenital or vaginal infection in the last 30 days;
• Have used topical or systemic antibiotics, antifungals, hormone-based creams or treatment for vaginal atrophy in the last 30 days.